grant
Quantitative Gait Metrics to Assess and Predict Gross Motor Impairment in Young Children with Neurofibromatosis Type 1
Organization NEW YORK UNIVERSITY SCHOOL OF MEDICINELocation NEW YORK, UNITED STATESPosted 1 Feb 2026Deadline 31 Jan 2031
NIHUS FederalResearch GrantFY20260-11 years old6 year old6 years of ageAI basedAddressAdvisory CommitteesAffectAmericanAreaAwardChildChild YouthChildhoodChildren (0-21)ClinicClinicalClinical TrialsClinical Trials DesignContralateralCounselingDataDevelopmentDiseaseDisorderEvaluationFamilyFeasibility StudiesFutureGaitGait AnalysisGait speedGoalsHereditaryHourInheritedInterventionInvestigatorsK23 AwardK23 MechanismK23 ProgramKnowledgeLegLogistic RegressionsMeasurementMeasuresMedicalMentored Patient-Oriented Research Career Development AwardMentored Patient-Oriented Research Career Development Award (K23)MentorsMentorshipMethodologyMethodsModelingMonitorMotorMovementMultiple NeurofibromasMuscleMuscle TissueNINDSNational Institute of Neurological Diseases and StrokeNational Institute of Neurological Disorders and StrokeNervous System DiseasesNervous System DisorderNeural DevelopmentNeurodevelopmental DisabilityNeurofibromatosesNeurofibromatosisNeurofibromatosis 1Neurofibromatosis INeurofibromatosis SyndromeNeurologic DisordersNeurological DisordersObservational StudyOutcomeOutcome MeasurePatient CarePatient Care DeliveryPatient CompliancePeer GroupPerformancePeripheral NeurofibromatosisPhasePhysiatric ProcedurePhysical FunctionPhysical Medicine ProcedurePhysical TherapeuticsPhysical therapyPhysiciansPhysiotherapyPositionPositioning AttributePrecision therapeuticsProxyROC AnalysesROC CurveRecklinghausen Disease of NerveRecklinghausen's diseaseRecklinghausen's neurofibromatosisRegression AnalysesRegression AnalysisRegression DiagnosticsResearch PersonnelResearch ResourcesResearchersResourcesRoleSchoolsScientistSeveritiesShapesSportsStatistical RegressionStrategic PlanningSurvey InstrumentSurveysSystemTask ForcesTestingTherapeutic InterventionTherapy Clinical TrialsTimeTrainingTraining ProgramsType 1 NeurofibromatosisType I NeurofibromatosisUncertaintyUnited StatesVisitWalkingWorkadvisory teamage 6age 6 yearsarmartificial intelligence basedbiomarker validationbody movementcare for patientscare of patientscareer developmentcaring for patientsclinical examclinical examinationclinical relevanceclinical trial readinessclinically relevantcomputer based predictiondesigndesigningdetermine efficacydevelop therapydevelopmentaldoubtearly childhoodefficacy analysisefficacy assessmentefficacy determinationefficacy evaluationefficacy examinationevaluate efficacyexamine efficacyexperiencegait examinationimprovedintervention developmentintervention therapykidsmarker validationmeasurable outcomemetermotor impairmentmovement impairmentmovement limitationmuscularneurodevelopmentneurogeneticsneurological diseasenovelobservational research studyobservational surveyoutcome measurementpatient adherencepatient cooperationpediatricphysical impairmentprecision therapiesprecision treatmentpredictive modelingprognosticprognostic abilityprognostic powerprognostic utilityprognostic valueprognosticationprospectivepsychosocialreceiver operating characteristic analysesreceiver operating characteristic curveresponse to therapyresponse to treatmentsix year oldsix years of ageskillssocial roletherapeutic responsetherapy developmenttherapy responsetooltreatment developmenttreatment planningtreatment responsetreatment responsivenessvon Recklinghausen Diseaseyoungster
Description preview
Project Summary/Abstract
Most children with neurofibromatosis type 1 (NF1), one of the most common inherited neurological disorders in
the United States, experience difficulties with large muscle movements. Current methods of measuring gross
motor impairment in young children with NF1 are time- and resource-intensive, reliant on coarse scoring…
🔒
Start 7-day free trial — $29.99/mo →Full details available on the Agency plan
Unlock the complete grant description, eligibility criteria, contract value, evaluation details and apply link — plus alerts, pipeline tracking, and CSV export.
Agency Plan
7-day free trialUnlock procurement & grants
Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.
$29.99 / month
- 🔔Email alerts for new matching tenders
- 🗂️Track tenders in your pipeline
- 💰Filter by contract value
- 📥Export results to CSV
- 📌Save searches with one click